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https://doi.org/10.1016/j.celrep.2020.108642SUMMARYThalamic astrocytes and oligodendrocytes are coupled via gap junctions and form panglial networks. Here,
we show that these networks have a key role in energy supply of neurons. Filling an astrocyte or an oligoden-
drocyte in acute slices with glucose or lactate is sufficient to rescue the decline of stimulation-induced field
post-synaptic potential (fPSP) amplitudes during extracellular glucose deprivation (EGD). In mice lacking
oligodendroglial coupling, loading an astrocyte with glucose does not rescue the EGD-mediated loss of
fPSPs. Monocarboxylate and glucose transporters are required for rescuing synaptic activity during EGD.
In mice deficient in astrocyte coupling, filling of an oligodendrocyte with glucose does not rescue fPSPs dur-
ing EGD. Our results demonstrate that, in the thalamus, astrocytes and oligodendrocytes are jointly engaged
in delivering energy substrates for sustaining neuronal activity and suggest that oligodendrocytes exert their
effect mainly by assisting astrocytes in metabolite transfer to the postsynapse.INTRODUCTION
Glial cells are key elements to guarantee proper brain function by
providing energy substrates to neurons. Astrocytic endfeet are
strategically located in close contact to blood vessels and cover
a large part of their surfaces. Astrocytes, as well as capillary
endothelial cells, express the glucose transporter, GLUT1, which
allows astrocytes to take up glucose from the circulation (Bé-
langer et al., 2011). Glucose is then metabolized to lactate by
glycolysis. Described by Pellerin and Magistretti (1994) as the
astrocyte-neuron lactate shuttle (ANLS), astrocyte-derived
lactate is then transported to the synapse, via monocarboxylate
transporters (mainly MCT4 in astrocytes and MCT2 in neurons),
to fuel neurons (Pellerin and Magistretti, 1994). In addition,
glycogen, which is almost exclusively localized to astrocytes,
serves as a significant energy reserve for the brain. Glycogen
breakdown also results in lactate production, is released in the
extracellular space, and is taken up by neurons to fuel their en-
ergy needs (Magistretti et al., 1993; Bélanger et al., 2011).
Rouach et al. (2008) demonstrated that, in the hippocampus, de-
livery of glucose or lactate from astrocytes is needed to maintain
neuronal synaptic transmission during extracellular glucose
deprivation (Rouach et al., 2008). Gap junction coupling among
astrocytes is required for this protective effect. Gap junctions
are formed by connexin proteins (Cx), which are expressed in
a cell-type-specific manner (Goodenough et al., 1996; BednerC
This is an open access article undet al., 2012). They allow intercellular exchange through diffusion
of small molecules, such as ions, second messengers, and en-
ergy metabolites, including glucose and lactate (Giaume et al.,
2010).
The thalamus has been described as the gate to conscious-
ness (Crick and Koch, 2003) because it has a key role in relay
and modulation of sensory and motors signals to the neocortex
(Sherman and Guillery, 2002) as well as in the generation of
sleep-related rhythms (Crunelli and Hughes, 2010). In
the thalamus, unlike the neocortex or the hippocampus, many
astrocytes lack Cx43 but, instead, abundantly express Cx30
(Griemsmann et al., 2015). Oligodendrocytes mainly express
the Cx isoforms Cx32 and Cx47. Tracer filling of individual
thalamic glial cells revealed abundant astrocyte-oligodendro-
cyte coupling, called panglial coupling. This is different from
other brain regions, e.g., the hippocampus and the neocortex,
in which panglial coupling is much less prevalent (Griemsmann
et al., 2015). The functional effect of oligodendrocytes within
these gray matter panglial networks is still unclear. It has been
shown that, in white matter, networks of coupled oligodendro-
cytes support the axonal function by transport of metabolites
(Lee et al., 2012; Meyer et al., 2018). Thus, because oligodendro-
cytes are not in direct contact with blood vessels, panglial
coupling in the thalamus might be needed to transport energy
metabolites from the circulation, via astrocytes and oligodendro-
cytes, to synaptic structures and/or to axons. Here, we assessedell Reports 34, 108642, January 19, 2021 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Slice preparation and evaluation of
fPSPs
(A) Scheme of a coronal section of a mouse brain
containing cortex (CO), internal capsule (IC), retic-
ular thalamic nucleus (RTN), and ventrobasal thal-
amus (VB). In addition, the hippocampus (HC) is
displayed, and the cross indicates slice orientation
(bottom). The cortico-thalamic pathway is indicated
by a green neuron, the thalamo-cortical pathway is
shown in blue, and a GABAergic neuron of the RTN
is displayed in brown. Stim, stimulation electrode;
Rec, recording electrode. Modified from (Grant et
al., 2012).
(B) Slice used for recordings; inset shows stimula-
tion and field recording electrodes.
(C) Stimulation trains of five pulses (indicated by
arrows) were applied and repeated every 15 s. The
depicted averages of 10 successive traces were
used for analysis. Scale bar, 20 ms, 0.5 mV. A blow-
up of the fourth response is shown. Scale bar,
10 ms, 0.5 mV.
(D) Timeline of the experimental protocols.
(E) fPSPs were sensitive to blockers of ionotropic
glutamate receptors (middle trace) but not GABAA
receptors (top). The bottom trace shows a recording
after TTX application (residual signals are stimula-
tion artifacts). Scale bar, 20 ms, 0.2 mV.
(F) Scheme depicting fPSP analysis by a custom-
made Igor Pro tool, by placing three measuring
points on the trace (gray circles). fPSP amplitude
(blue dotted line) was determined as the distance
between the intersection of the tangent and the
minimum of the second negative deflection.
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OPEN ACCESSwhether, and through which mechanisms, oligodendrocytes in
the thalamus are participating in the energy provision of neurons.
By stimulating the cortico-thalamic pathway, we found that
extracellular glucose deprivation (EGD) suppresses thalamic
post-synaptic field potentials (fPSPs), which could not be
rescued by extracellular lactate or pyruvate. Importantly, the
loss of fPSPs during EGD was fully prevented when filling an in-
dividual astrocyte with glucose or lactate, a process that
required glucose and monocarboxylate transporter activity.
Filling of individual oligodendrocyte with glucose also rescued
fPSPs during EGD. Thus, in the thalamus, astrocytes and oligo-
dendrocytes are jointly engaged in maintaining synaptic activity
by delivery of metabolites through the panglial coupling network.
RESULTS
Characterization of post-synaptic field potentials in the
ventrobasal thalamus
To record thalamic fPSPs, coronal brain slices with a 30 angle to
the horizontal plane were prepared. A bipolar stimulation elec-
trode was placed into the internal capsule, and the field
recording electrode was located at the ventrobasal thalamus2 Cell Reports 34, 108642, January 19, 2021(Figures 1A and 1B). Stimulation of the cortico-thalamic pathway
(indicated by the green neuron in Figure 1A; five pulses, 100 ms at
20 Hz, every 15 s) in the presence of picrotoxin (100 mM), to block
GABAergic neurons of the reticular thalamic nucleus (RTN),
evoked fPSPs (Figures 1C–1F). The stimulation intensity was
set to elicit 80%of themaximal responses. This protocol allowed
for long-term monitoring (>1 h) of synaptic activity without
inducing long-term potentiation (LTP) or long-term depression
(LTD). fPSPs were isolated by subtracting responses evoked in
the presence of picrotoxin, D-AP5, and NBQX from responses
in artificial cerebrospinal fluid (ACSF) (Figures 1C and 1D).
Thalamic fPSPs were completely blocked by adding tetrodo-
toxin (TTX) (0.5 mM) to the bath solution (Figure 1E, bottom).
fPSP amplitudes were calculated as the voltage difference be-
tween the second peak (minimum) of the field potential and the
intersection of its extrapolated slope (dotted lines in Figure 1F).
EGD leads to a rapid decline of thalamic fPSPs and
cannot be rescued by bath application of lactate or
pyruvate
In ACSF containing 11 mM of glucose, stable fPSPs could be
recorded over >40 min (Figures 2A and 2B, black line, and
Figure 2. EGD-induced depression of thalamic fPSPs is Rescued by glucose or lactate filling of an astrocyte or oligodendrocyte
(A) Example traces of thalamic field potentials in slices from hGFAP-EGFP mice. Top: control recordings, indicated by black lines in (B), with numbers corre-
sponding to time points indicated in (B). Bottom: recordings obtained (1) before removal of extracellular glucose, (2) during EGD, and (3) after reperfusion with
glucose-containing bath solution, indicated by the orange lines in (B). Scale bars, 0.5 ms, 0.5 mV.
(B) Representative traces of thalamic fPSPs under control conditions (gluc+, black lines) and during a 10min of EGD (gluc, EGD, orange; n = 12, N = 10). Red and
pink curves represent fPSPs in which extracellular glucose was replaced by L-lactate (22 mM; n = 9, N = 5) or by pyruvate (22 mM, n = 6, N = 6), respectively.
(C) Bar graphs represent the means and SEM of the remaining fPSP amplitudes, normalized to the respective condition before EGD. Extracellular lactate and
pyruvate did not rescue the EGD-induced decline of fPSPs. Number of mice is given in the bar graphs.
(D) Boxplots represent the median of the slope (fPSP%/min) of the respective condition using linear approximation and comparing the steepness of the curves.
Extracellular lactate and pyruvate did not affect fPSP slope compared with the EGD-only experiments.
(E) Representative traces of fPSPs during EGD (EGD, orange, n = 12, N = 10; same EGD trace is shown for comparison in Figures 2, 3, and 4), during EGD after
filling an hGFAP-EGFP-positive astrocyte with glucose (20mM, EGD+AG, dark green; n = 8, N = 7) and during EGD after filling an astrocyte with L-lactate (40 mM,
EGD+AL, light green; n = 7, N = 6). The bar graphs (right) compare the amplitudes of the fPSPs remaining under the respective conditions, normalized to am-
plitudes before EGD. Astrocytes loaded with glucose or lactate could partially rescue thalamic fPSP amplitudes during EGD. Error bars represent SEM.
(F) Representative recordings of fPSPs during EGD (EGD, orange, n = 12, N = 10), during EGD after filling a PLP-GFP-positive oligodendrocyte with glucose
(20mM, EGD+OG, dark blue; n = 9, N = 7), and during EGD after filling an oligodendrocyte with L-lactate (40 mM, EGD+OL, light blue; n = 5, N = 5). The histogram
(right) compares the fPSPs remaining under the respective conditions, normalized to the amplitudes before EGD. Loading of oligodendrocytes with glucose or




OPEN ACCESSFigure 1). For EGD experiments, first, control fPSPs were re-
corded in ACSF (10 min); then, glucose was removed from
the bath (10 min; gluc-), and subsequently, ACSF was re-
perfused (30 min). During EGD, fPSPs declined to around
45% of the initial amplitude and recovered upon reperfusion
with ACSF (Figure 2, orange line and bar graph). Similar to the
corpus callosum (Meyer et al., 2018), extracellular replacement
of glucose with equistoichiometric amounts of L-lactate (22 mM,
n = 5) or pyruvate (22 mM, N = 6) did not rescue the transient
decline of fPSPs, with the drop to about 60% of the controlvalue being not statistically different from that observed in
ACSF lacking glucose (Figures 2B and 2C; p = 0.13 and 0.10
for L-lactate and pyruvate, respectively). Reperfusion of glucose
after lactate or pyruvate application led to a similar recovery of
fPSPs as that observed after EGD. The kinetics of the fPSP
decline was analyzed using linear approximation of the decay
and comparing the slopes. There was no significant difference
when comparing the EGD-only condition with the EGD + lactate
and EGD + pyruvate conditions (Figure 2D; p = 0.307, Kruskal-
Wallis).Cell Reports 34, 108642, January 19, 2021 3
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OPEN ACCESSThe decline of fPSPs during EGD can be rescued by
filling an astrocyte with glucose or lactate
We investigated whether, in the thalamus, metabolite loading of
glial cells counterbalances the EGD-mediated loss of fPSP am-
plitudes. Astrocytes were identified by employing acute brain sli-
ces from hGFAP-GFAP mice. Although thalamic astrocytes are
almost devoid of GFAP protein, many of them express hGFAP
promoter activity and can be identified by their intrinsic fluores-
cence andmorphology (Griemsmann et al., 2015; Matthias et al.,
2003). An astrocyte was patched and filled through the pipette
solution with a high concentration of glucose (20 mM, 20 min).
Subsequently, EGD was performed (10 min), followed
by reperfusion of the ACSF. The pipette solution also contained
the gap-junction-permeable dye sulforhodamine-B to monitor a
successful spread into the coupled networks. The patched cells
displayed electrophysiological properties typical of astrocytes,
including a very low input resistance (2.9 ± 0.3 MU; n = 15, N =
14). Glucose filling of an astrocyte significantly reduced the
EGD-dependent drop of fPSPs (control EGD, same as in Fig-
ure 2C, to 45 ± 5%, N = 10; after astrocyte filling, to 71 ±
5.5%; N = 7; p = 0.004) (Figure 2E). We also tested whether filling
of astrocytes with L-lactate (40 mM, N = 6, because during lactic
fermentation 1 molecule of glucose generates 2 molecules of
lactate) can rescue fPSP. Indeed, under this condition, the
EGD-induced drop of fPSPs was also reduced (to 66 ± 3.26%;
n = 6, p = 0.014) (Figure 2E). In conclusion, high glucose or L-
lactate filling of astrocytes can rescue the decline of fPSP ampli-
tudes during EGD in the thalamus.
Filling an oligodendrocyte with glucose or lactate also
rescues fPSPs during EGD in the thalamus
We have previously reported that, in the thalamus, astrocytes and
oligodendrocytes form abundant panglial coupling networks
(Griemsmann et al., 2015; Claus et al., 2018). In the
corpus callosum, Meyer et al. (2018) demonstrated a critical role
for oligodendrocytes, rather than astrocytes, in coupling-depen-
dent provision of energy substrates to prevent the decline of
axonalactivityduringEGD.To testwhetheroligodendrocytessimi-
larly protect synaptic activity in the thalamus, individual oligoden-
drocytes of PLP-GFP mice were filled with glucose (20 mM) or
lactate (40 mM), and fPSPs were recorded as described above.
The input resistance of the cells was 7.7 ± 4.1 MU (n = 13, N =
12). Similar to dialyzing astrocytes with energy metabolites,
loading of oligodendrocytes with high glucose concentration
(20 mM, N = 7) significantly reduced the decline of fPSPs during
EGD (to 68 ± 3%, p = 0.01). Loading an oligodendrocyte with
lactate (40 mM, N = 5) had a comparable effect (decline to 66 ±
4%, p = 0.031) (Figure 2F). In conclusion, filling of individual astro-
cytes or oligodendrocytes with energy substrates is equally effi-
cient at attenuating EGD-induced impairment of fPSP activity in
the thalamus.
The protective effect of astrocyte glucose filling on fPSP
activity requires astrocyte-oligodendrocyte gap
junction coupling
In the thalamus, Cx30 is the dominating astrocytic connexin,
and astrocyte-oligodendrocyte coupling is mainly mediated
by heterotypic Cx32:Cx30 channels (Griemsmann et al.,4 Cell Reports 34, 108642, January 19, 20212015; Claus et al., 2018). To investigate the putative effect of
oligodendrocyte coupling on energy substrate provision, we
first investigated the coupling efficiency by filling a thalamic
astrocyte in Cx32/;Cx47 EGFP(/) (dko) (n = 10, N = 3),
Cx32/;Cx47EGFP(+/) (n = 11, N = 4) and Cx32/;Cx47+/+
mice (n = 15, N = 4) with biocytin (during 20 min of patch clamp
recording; Figures 3A and 3C). Coupling efficiency was signif-
icantly reduced in dko mice (36 ± 8 cells, n = 10 slices),
compared with that of Cx32/;Cx47EGFP(+/) mice (69 ± 11
cells, n = 11 slices, p = 0.048) (Figure 3A) and of control mice
(110 ± 20 cells from PLP-GFP mice, p = 0.0028; (Griemsmann
et al., 2015), whereas it did not differ from Cx32/;Cx47+/+
mice (58 ± 2 cells, n = 15 slices, p = 0.12). Furthermore, in
the Cx32/;Cx47EGFP(+/) mice, among those coupled cells,
27% were GFP+ (Figures 3A and 3C, white arrows indicate
some examples), i.e., oligodendrocytes (versus 55% in control
mice). In dko mice, no coupled GFP+ cells were seen, i.e., oli-
godendrocytes were completely uncoupled.
Next, we investigated whether, in Cx32/Cx47 dko mice, the
protection of fPSP activity during EGD through glucose filling of
astrocytes was affected. In thesemice, Cx47-positive cells never
colocalized with the astrocytic marker SR101 (Nimmerjahn et al.,
2004; Kafitz et al., 2008) (not shown). Thus, astrocytes were iden-
tified as non-fluorescent cells with passive membrane currents
and very low input resistance (1.8 ± 0.3MU; n = 6, N = 6). In addi-
tion, the cell was filled with sulforhodamine B (10 mg/mL) to visu-
alize coupling online and to ensure that the patched cell was an
astrocyte. In Cx32/Cx47 dko mice, filling of an astrocyte
(20 min) with glucose (20 mM) did not rescue fPSP amplitudes
during EGD (light gray, 53.8%± 6.4%,N = 6) comparedwith con-
trol experiments (dark gray, 46.6% ± 5.1%, N = 5) (Figure 3B, p =
0.87). These values were also similar to the fPSP decline during
EGD in hGFAP-EGFP mice (orange bar in Figure 3B was taken
from Figure 2C for comparison, p = 0.99 and 0.68, respectively).
Rescue of fPSPs during EGD through intercellular
glucose provision is sensitive to the activity of glucose
and monocarboxylate transporters
We next asked which glial and neuronal transporters participate
in the rescue of synaptic activity in the thalamus. Therefore, EGD,
filling of an astrocyte with glucose, and fPSP recording
were performed while inhibiting glucose and monocarboxylate
transporters. First, we co-applied AR-C155858 (1 mM; inhibits
monocarboxylate transporters MCT1 in oligodendrocytes and
MCT2 expressed by neurons) and Stf31 (5 mM; blocks glucose
transporter GLUT1 expressed by astrocytes and oligodendro-
cytes). Under those conditions, no rescue of fPSPs during EGD
was observed when filling an astrocyte with high glucose (Fig-
ure 4A, dark green bar, N = 6) because the fPSPs declined to a
similar extent as that without intracellular glucose provision (to
45% ± 8% and 45% ± 5%; orange bar taken from Figure 2C,
p = 0.99). Co-application of AR-C155858 and Stf31 in control
ACSF (i.e., with glucose) moderately reduced fPSPs (p =
0.0145) (Figure 4B, brown, N = 7). This inhibition was significantly
less compared with EGD experiments in which those blockers
were applied after filling an astrocyte with glucose (73% ± 4%
versus 45% ± 8%, p = 0.014). SR13800 (0.01 mM), anMCT1-spe-
cific inhibitor, did not affect fPSPs during EGD while glucose
Figure 3. In Cx32/Cx47 dko mice, glucose filling of an astrocyte does not rescue the EGD-mediated decline of thalamic fPSPs
(A) Quantification of coupling efficiency in different mouse genotypes after filling SR101+ thalamic astrocytes with biocytin (20 min). Total numbers (black bars) as
well as the numbers of GFP+ oligodendrocytes (gray bars) among all biocytin-coupled cells were compared. In Cx32/;Cx47EGFP(/) (dko) mice (n = 10, N = 3),
the remaining small networks completely lacked oligodendrocytes; they were used for further experiments. As expected, significantly smaller biocytin-positive
networks were observed in Cx32/Cx47 dko mice compared with that of Cx32/;Cx47EGFP(+/) (n = 11, N = 4) and control (n = 14, N = 8) mice, with the latter
containing 27% and 55% oligodendrocytes, respectively. In Cx32/;Cx47+/+mice, the proportion of oligodendrocytes was not determined because they were
not fluorescent (n = 15, N = 4). The number of mice is given in the bar graphs, and error bars represent SEM. Kruskal-Wallis test followed by Dunn’s test. For
comparison, the control data were obtained from Griemsmann et al. (2015).
(B) Representative traces of fPSP changes during EGD in hGFAP-EGFP (EGD, orange; n = 12, N = 10) and in Cx32/Cx47 dkomice (EGD dko, dark gray; n = 5, N =
5). In addition, fPSP changes during EGD after prior filling of an astrocyte with glucose in hGFAP-EGFP (20 mM EGD+AG, green; n = 7, N = 6) and in Cx32/Cx47
dko mice (EGD dko+AG, light gray; n = 6, N = 6) are shown. Loading an astrocyte with glucose in Cx32/Cx47 dko mice did not attenuate the EGD-mediated
decline of fPSPs. The number of mice is given in the bar graphs, and error bars represent SEM. ANOVA followed by Tukey’s post hoc test. *p < 0.05.
(C) Immunostaining of SR101+ astrocytes filled with biocytin for 20 min in the thalamus of three different genotypes: Cx32/;Cx47+/+ (A1–A3),
Cx32/;Cx47EGFP(+/) (B1–B3), and Cx32/;Cx47EGFP(/) (C1–C3). Cx47-EGFP-fluorescent oligodendrocytes are displayed in green (B2–C2), and the merged
images are shown (A3–C3). Note that EGFP is not expressed in the Cx32/;Cx47+/+mice (A2). Immunostaining for GFP (B2 and B3) revealed biocytin spread into
Cx47-EGFP-fluorescent oligodendrocytes in the Cx32/;Cx47EGFP(+/) mice, as indicated by the co-localization of both markers (yellow cells, white arrow, B3).
Scale bar, 40 mm.
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OPEN ACCESSfilling (dark purple, N = 6) compared with EGD-only or EGD+AG
(Figure 4C, p = 0.38 and 0.64, respectively). Similarly, although
loading an astrocyte with glucose, AR-C155858 (light pink, n =
6) and Stf31 (light purple, N = 6) alone also failed to affect fPSPs
during EGD (p = 0.21 and 0.20) or EGD+AG (p = 0.84 and 0.87,
respectively) (Figure 4C). In conclusion, both MCT1/2 and
GLUT1 transporters are involved in the rescue of synaptic activ-
ity when providing energy substrates through the coupled pan-
glial thalamic network.Finally, we asked whether, in mice lacking astrocyte gap junc-
tion coupling (Cx30/;Cx43fl/fl:hGFAPCre (DKO) mice; Wallraff
et al., 2006), the protection of fPSP activity during EGD through
glucose filling of oligodendrocytes was still affected. In those
mice, SR101 was used to label astrocytes in the slices, and oli-
godendrocytes were identified as SR101-negative cells with
typical passive membrane current patterns. In addition, the
selected cells were dye coupled as evidenced online by adding
sulforhodamine B to the pipette solution. We found that, in theCell Reports 34, 108642, January 19, 2021 5
Figure 4. Simultaneous inhibition of glucose and monocarboxylate transport precludes the rescue of synaptic activity upon astrocyte
glucose loading
(A) Representative traces of fPSP changes (left) and remaining fPSP amplitudes (right) during EGD in hGFAP-EGFPmice (EGD, orange, n = 12, N = 10) after filling a
fluorescent astrocyte with glucose (20 mM, EGD+AG, green, n = 7, N = 6), or after filling an astrocyte with glucose (20 mM) and applying Stf-31 (5 mM) and AR-
C155858 (1 mM) to blockGLUT1,MCT1, andMCT2 (EGD+AG+Stf/AR-C appl., dark green, n = 6, N = 6). In the latter case, the rescue of fPSPswas abolished. Error
bars represent SEM.
(B) Representative traces of fPSP changes (left) during a 10-min co-application of Stf31 and AR-C155858, when glucose was continuously perfused (Stf/AR-C
appl., brown, n = 8, N = 7) and during EGD after filling an astrocyte with glucose (20 mM, EGD+AG+Stf/AR-C appl., dark green, n = 6, N = 6). The application of
both blockers led to a moderate decrease in fPSPs, which was significantly lower compared with EGD experiments in which the rescue of fPSPs was abolished
when those blockers were applied after loading an astrocyte with glucose (right). Error bars represent SEM.
(C) Representative traces of fPSP changes (left) obtained after filling an astrocyte with glucose (20mM)when theMCT1-specific blockers SR13800 (0.01 mM), AR-
C155858 (1 mM), or Stf-31 (5 mM)were applied (EGD+AG+SR13800, purple, n = 6, N = 6; EGD+AG+STf, light purple, n = 7, N = 6; EGD+AG+AR-C, light pink, n = 8,
N = 6). None of those blockers alone affected the loss of fPSPs during EGD or EGD+AG (right). Error bars represent SEM.
(D) Representative traces of fPSP changes (left) during EGD after previous filling of an oligodendrocyte with glucose in hGFAP-EGFP (20 mM, EGD+OG, dark
blue; n = 9, N = 7) or Cx30/Cx43 DKO (EGD DKO + OG, dark gray; n = 3, N = 2) mice. The histogram (right) compares fPSPs remaining under the respective
conditions, normalized to the amplitudes before EGD. Note that loading an oligodendrocyte in the Cx30/Cx43 DKO mice did not attenuate the EGD-mediated
decline of fPSPs. Error bars represent SEM.
The number ofmice is given in bar graphs, except for (D), inwhich the number of slices is given. ANOVA followedbyTukey’s post hoc test or t test (B andD). *p < 0.05.
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(20 min) with glucose (20 mM) failed to rescue fPSP amplitudes
during EGD (dark gray, 45.1% ± 10.8%, n = 3, N = 2, p = 0.26;
Figure 4D).
DISCUSSION
In the hippocampus, glial gap junction networks enable traf-
ficking of energy metabolites to maintain glutamatergic synaptic6 Cell Reports 34, 108642, January 19, 2021activity (Rouach et al., 2008). These networks are almost exclu-
sively formed by astrocytes expressingCx43 (Griemsmann et al.,
2015). In contrast, in the corpus callosum, panglial networks are
dominated by oligodendrocytes (Meyer et al., 2018), indicating
that glial properties are heterogeneous across brain areas (Xin
and Bonci, 2018; Matyash and Kettenmann, 2010). The molecu-
lar and functional characteristics of astrocytes in the thalamus
also show distinct features and thus differ from those of other re-
gions, e.g., the hippocampus or neocortex. Thalamic astrocytes
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sical’’ astroglial markers, such as GFAP and ALDH1L1. Notably,
thalamic networks of coupled glial cells are equally composed of
astrocytes and oligodendrocytes (Höft et al., 2014; Griemsmann
et al., 2015; Claus et al., 2018). We, therefore, addressed the
question of whether oligodendrocytes within the thalamic pan-
glial network are needed for the provision of energy substrates
to maintain neuronal activity.
The thalamus is a brain region of high energy consumption
(Gordji-Nejad et al., 2018), probably also because of its long-
range signaling pathways and metabolic needs for myelination.
After having established a method to quantify post-synaptic
network activity in slices from the ventrobasal thalamus, we
investigated whether extracellular glucose can be replaced by
lactate or pyruvate to maintain fPSPs. Indeed, several recent
studies, mainly in the optic nerve, but also in spinal cord, have
demonstrated that delivery of these substrates by oligodendro-
cytes is critical for axonal function (Hirrlinger and Nave, 2014;
F€unfschilling et al., 2012; Brown et al., 2003; Lee et al., 2012).
On the other hand, astrocytes have been shown to produce
lactate, either from glucose or glycogen, and to deliver it to neu-
rons through the astrocyte-neuron lactate shuttle (ANLS) (Pel-
lerin and Magistretti, 2012). Thus, oligodendrocytes in the
thalamic network might help sustain presynaptic function,
whereas astrocytes through the ANLSmight supply post-synap-
tic elements with energy.We found that EGD-induced decreases
in fPSPs could not be prevented by extracellular lactate or pyru-
vate. Similar observations were made in the corpus callosum
(Meyer et al., 2018), whereas, in the optic nerve, lactate may
replace glucose to preserve axonal function (Brown et al.,
2003). Compared with the hippocampus (Rouach et al., 2008),
fPSPs declinedmuch faster after onset of EGD, whichmight indi-
cate a higher energy consumption in the thalamus because of
structural differences between both regions (cf. above). During
metabolic challenges, astrocytes may also deliver lactate
derived from glycogen (Pellerin and Magistretti, 2012), and lower
glycogen storage would entail a faster decline of energy reserves
for neurons. Indeed, regional differences in metabolic roles
imposed by astrocytes have been reported. Inhibition of gluta-
mine synthetase led to massive glycogen accumulation in astro-
cytes of the hippocampus and neocortex but not in the thalamus
(Yamamoto et al., 1989). Evidence for regional differences in
glycogen content came from a recent immunohistochemical
study revealing much lower glycogen labeling in astrocytes of
the thalamus compared with other brain regions. Thus, the rapid
fPSP decline during EGD in the thalamus might reflect lower
glycogen reserves of those astrocytes (Oe et al., 2016).
Next, we investigated whether loading the panglial coupling
network with energy substrates rescued the EGD-induced
fPSP decline. We are aware that the loaded glucose concentra-
tion of 20 mM is much higher than the physiological condition.
However, we assumed that there is considerable decay from
the concentration in the pipette into the loaded astrocyte and,
even more so, into the coupled network because of diffusion
resistance. For better comparison, we used the same experi-
mental conditions as those for the corresponding analyses in
the corpus callosum (Meyer et al., 2018). Filling glucose or
lactate into a single astrocyte largely prevented the decline ofsynaptic activity during EGD. Filling individual oligodendrocytes
with the substrates had a similar effect, suggesting that the pan-
glial networks use both astrocytes and oligodendrocytes to
transport energy metabolites from blood vessels to thalamic
neurons. To further substantiate a role for oligodendrocytes in
sustaining synaptic activity, mice with genetic deletion of Cx32
and Cx47 were employed. These connexins are crucial for
proper central myelination and oligodendrocytic coupling (Meni-
chella et al., 2003; Odermatt et al., 2003; Maglione et al., 2010;
Griemsmann et al., 2015). As expected, mice devoid of both con-
nexins showed complete lack of oligodendrocyte coupling.
Filling an astrocyte with glucose in those double-deficient mice
could not rescue fPSPs during EGD. Thus, oligodendrocytes
are key elements of the panglial networks for the proper neuronal
energy supply in the thalamus.
Based on findings from the hippocampus, optic nerve, and
corpus callosum, one may speculate that astrocytes support
neurons at the synapse, whereas oligodendrocytes support
them at the axons. Our stimulation paradigm includes both ele-
ments, action potential propagation via axons and synaptic
transmission, and onemay assume that these two glial cell types
subdivide their task in supporting the neuron.
In the optic nerve, axonal activity provokes glucose uptake
into oligodendrocytes through incorporation of GLUT1 into the
oligodendrocytic membrane, a mechanism not requiring gap
junction coupling but NMDA receptors (Saab et al., 2016). In
contrast, the neuronal energy supply in the thalamus was
disturbed in mice with coupling-deficient oligodendrocytes.
Even though we still don’t know whether thalamic oligodendro-
cytes lack GLUT1 and/or NMDA receptors, these finding add
to the emerging view that the properties of glial cells in the thal-
amus are distinct from those of other brain regions (Claus et al.,
2018; Griemsmann et al., 2015). Oligodendrocytes in the optic
nerve show lower coupling efficiency (Butt and Ransom, 1989)
and obviously have developed alternative strategies to fuel
neurons.
According to the ANLS hypothesis, glucose can be taken up
by astrocytes from blood vessels via GLUT1 (Bélanger et al.,
2011; Barros and Deitmer, 2010). Astrocytes convert glucose
into lactate and export it via MCT4 (Rafiki et al., 2003; Rinholm
et al., 2011). MCT1 is expressed by oligodendrocytes and pre-
dominantly localized to the myelin sheaths around axons.
Lactate can then be taking up by MCT2 to pre- or post-synaptic
neurons (Pierre and Pellerin, 2005; Lee et al., 2012). In the corpus
callosum, oligodendrocyte-derived glucose, rather than lactate,
contributes to metabolic support of axons (Meyer et al., 2018).
We applied inhibitors of GLUT1 and MCT1/2 to reveal whether
panglial fueling of neurons in the thalamus involves pre-synaptic
or post-synaptic mechanisms or both. Simultaneous blockage of
MTCs and GLUT1 completely abolished the rescue of fPSPs
observed upon astrocyte glucose loading during EGD. In
contrast, the effect of blocking only GLUT1 or MCT1/2 alone,
as well as the effect of SR13800, an MCT1-specific blocker,
was difficult to interpret because the remaining amplitude was
not different from the control situation (EGD).
To further discern how oligodendrocytes exert their effect on
fPSP rescue during EGD, mice with genetic deletion of Cx30
and Cx43, in which astrocytes are completely uncoupled, wereCell Reports 34, 108642, January 19, 2021 7
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OPEN ACCESSemployed (Wallraff et al., 2006). Filling an oligodendrocyte with
glucose in those mice did not rescue fPSPs during EGD, sug-
gesting that oligodendrocytes within the panglial network exert
their protective effects mainly by assisting metabolite transport
of astrocytes to the postsynapes, although further experiments
are needed to finally resolve that issue.
Taken together, we show that astrocytes and oligodendro-
cytes in the thalamus are jointly engaged in maintaining synaptic
activity by delivery of metabolites through the panglial-coupled
network (Morrison et al., 2013). The underlying mechanisms
are clearly different from other gray and white matter regions of
the brain. Our data support the view that thalamic oligodendro-
cytes exert their effect mainly by assisting metabolite transport
of astrocytes to the postsynapse, rather than by fueling axons
or pre-synaptic structures.STAR+METHODS
Detailed methods are provided in the online version of this paper
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bius, W., Goetze, B., Jahn, H.M., Huang, W., et al. (2016). Oligodendroglial
NMDA receptors regulate glucose import and axonal energy metabolism.
Neuron 91, 119–132.
Sherman, S.M., and Guillery, R.W. (2002). The role of the thalamus in the flow
of information to the cortex. Philos. Trans. R. Soc. Lond. BBiol. Sci. 357, 1695–
1708.
Wallraff, A., Köhling, R., Heinemann, U., Theis, M., Willecke, K., and Stein-
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Data and code availability
The article includes all data generated or analyzed during this study. Original source data for Figures in the paper are available upon
request to the Lead Contact author. No proprietary software was used in the data analysis.
EXPERIMENTAL MODEL
Mice
Experiments were performed in transgenic mice with astrocyte-specific fluorescence labeling (human glial fibrillary acidic protein-
enhanced green fluorescent protein (hGFAP-EGFP); (Nolte et al., 2001), astrocyte-specific knockout of Cx43 and global deletion
of Cx30 [(Cx30/;Cx43fl/f:hGFAPCre (DKO)]; (Wallraff et al., 2006) or oligodendrocyte-specific fluorescence labeling (myelin proteo-
lipid protein-green fluorescence protein (PLP-GFP); (Fuss et al., 2000)). In Cx32/Cx47-deficient [Cx32/;Cx47EGFP(+/) and
Cx32/;Cx47EGFP(/) (dko)] mouse lines, oligodendrocytes could be identified by EGFP fluorescence as the Cx47 coding region
had been replaced by cDNA encoding the enhanced variant of the green fluorescent protein (Odermatt et al., 2003). As in our previous
studies (Meyer et al., 2018; Claus et al., 2018; Griemsmann et al., 2015), mice of both sexes were used for the experiments at post-
natal day (p) 28-40, except DKO mice which had an age of p23-24 . Animals were kept under standard housing conditions. All ex-




Animals were anesthetized with Isoflurane (Abbott, Wiesbaden, Germany) and killed by decapitation. The brains were then carefully
removed. The midline of each hemisphere was put on a custom-made Teflon block with a 30 angle and a small piece of the dorsal
part of the brain was cut off. The hemispheres were glued dorsally on a specimen holder and cut in ice cold solution containing (in
mM): 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 7 MgCl2, 0.5 CaCl2, 25 glucose, 61.3 sucrose and bubbled with carbogen (95%
O2/5% CO2) at pH 7,4. Using a vibratome (VT1200S, Leica, Nussloch, Germany), 300 mm thick slices for post synaptic field poten-
tial recordings and 200 mm thick slices for whole-cell patch clamp experiments, were prepared containing the ventroposteromedial
(VPM) and ventroposterolateral (VPL) nuclei of the thalamus. Slices were kept at 35C for 15 min and then stored in artificial ce-
rebrospinal fluid (ACSF) containing (in mM): 119 NaCl, 2.5 KCl, 1.3 MgSO4, 2.5 CaCl2, 11 glucose, 1 NaH2PO4 and 26.2 NaHCO3,
at room temperature for at least 1 h before starting the experiments. In some cases, the slices were incubated in ASCF supple-
mented with 1 mM sulforhodamine 101 (SR101; Invitrogen, Thermo Fisher Scientific, Darmstadt, Germany) to label astrocytes
(35C for 20 min).
Post-synaptic field potentials and data analysis
Slices were then transferred to a recording chamber and visualized using a Leica TCS SP5 confocal microscope (Leica DM6000,
Leica, Mannheim, Germany) and LAS AF software. It was equipped with a Leica HCX APO L 20x 1.0 water immersion objective
and differential interference contrast (DIC) optics. Slices were constantly perfused with carbogenized ACSF. To stimulate the cor-
tico-thalamic (CT) pathway, a bipolar stimulation electrode (WE3ST31.0A10, MicroProbes for Life Science, Gaithersburg, USA)
with outside diameter of 0.61 mm, tip separation of 250 mm and an impedance of 1.0 MU, was placed in the internal capsule. An
ACSF-filled recording electrode made from borosilicate glass capillaries with an outside diameter of 2 mm (Science Products, Hof-
heim, Germany) and a resistance of 3-6 MUwas located in the ventrobasal thalamus. The distance between the two electrodes was
about 700 mm. The depth of the stimulation electrode was adjusted to evokemaximal responses. Electrical stimulation was achieved
with a computer-controlled constant current isolated stimulator (STG2004, Multi Channels Systems, Reutlingen, Germany). Field po-
tentials were recorded in the ventrobasal thalamus with a SEC05-LX amplifier in the bridge mode (npi electronic, Tamm, Germany)
while applying trains of stimuli (duration 100 ms, 5 stimuli at 20 Hz, from 50 mA to 200 mA, every 15 s). Ten subsequent traces were
averaged and used for the analysis (giving one data point every 150 s). To obtain stable responses the stimulation intensity was set to
80% of the peak amplitude. Data analysis was performed with Igor Pro software (Wave Metrics, Portland, USA).
Extracellular glucose deprivation (EGD)
For EGD experiments, slices were first incubated with ACSF (10 min) for recording baseline fPSPs. Then, glucose-free ACSF was
applied for 10min and subsequently ACSF containing glucose was reapplied for 30min. In some experiments, glucose was replaced
by L-lactate or pyruvate (both Sigma-Aldrich, St.Louis, Missouri, USA) during the 10 min EGD step. Blockers for glucose and mono-
carboxylate transporters (AR-C155858, MedChemExpress, Sollentuna, Sweden; Stf31, Sigma-Aldrich, St.Louis, Missouri, USA andCell Reports 34, 108642, January 19, 2021 e2
Report
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OPEN ACCESSSR13800, Tocris Bioscience, Bristol, United Kingdom) were applied by bath perfusion during EGD. Experiments were performed at
room temperature because at 35C, EGD (duration 5-10min) caused an irreversible fPSP decline to zero while shorter EGD durations
(2.5 min) did not affect the field potential (data not shown).
Patch-clamp recordings
Whole-cell patch clamp experiments were performed on thalamic astrocytes and oligodendrocytes, which were identified based on
their morphology and green fluorescence (Matthias et al., 2003; Fuss et al., 2000; Odermatt et al., 2003). Patch pipettes were pulled
from borosilicate glass capillaries (Science Products, Hofheim, Germany) by a horizontal puller (DMZ Zeitz-Puller, Zeitz, Martinsried,
Germany) and had a resistance of 3-6 MU when filled with the following intracellular solution (in mM): 100 K-gluconate, 30 KCl, 0.5
CaCl2, 1MgCl2, 5 EGTA, 20 KOH, 3 Na2-ATP, 10 HEPES, supplemented with 20 glucose or 40 L-lactate. Sulforhodamine B (10 mg/ml;
Sigma-Aldrich, St.Louis,Missouri, USA) was added to the pipette solution to visualize the coupled network during recording. Patched
cells were selected close to the recording electrode (maximum distance 80 mm, same depth as the recording electrode). Cells were
dialyzed for 20min with the pipette solution prior to EGD to ensure saturation of metabolites spreading in the coupled networks. Cells
were clamped at 80 mV. The liquid junction potential, calculated using Clampex (7.1 mV), was compensated online. Input and
series resistance were regularly monitored applying 10mV voltage steps. Recordings with series resistance >20MUwere discarded.
Currents were recorded using an EPC-800 patch clamp amplifier (Heka, Lambrecht, Germany) and monitored by TIDA software
(Heka). Data were filtered at 3-10 kHz and sampled at 6-30 kHz.
QUANTIFICATION AND STATISTICAL ANALYSES
Quantification of tracer coupling
Tracer-filling experiments were performed to determine the size and composition of glial networks in acute thalamic brain slices of
Cx32/Cx47-defficient mice (Griemsmann et al., 2015). To identify astrocytes, 200 mm thick slices were incubated in ACSF supple-
mented with SR101. Currents were recorded and cells dialyzed for 20 min with intracellular solution supplemented with 0.5% bio-
cytin. After recording, slices were fixed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffered saline (PBS), pH 7.4, overnight
at 4C and subsequently stored in PBS. Slices were permeabilized and unspecific antibody binding sites were blocked by incubating
for 4 h at room temperature in PBS containing 2% Triton X-100 and 10% normal goat serum (NGS; Millipore). They were then incu-
bated with streptavidin-Alexa Fluor 647 (1:600; Thermo Fisher Scientific) and chicken-a-GFP (1:500; Abcam, Cambridge, UK;
ab13970) in PBS with NGS (2%) and Triton X-100 (0.1%) at 4C overnight. The next day, slices were washed 3 times in PBS and
incubated 2 h at room temperature with goat-a-chicken Alexa Fluor 488 (1:500; Invitrogen A11039). Slices were then washed 3 times
and incubated with Hoechst (Invitrogen; 1:100 in dH2O, 10 min). After another washing step, slices were mounted on coverslips
(Aqua-Poly/Mount, Polyscience). Stacks of image planes were acquired at a 1-2 mm intervals using a confocal microscope (TCS
SP8 Leica). Coupling networks were quantified by counting the total number of biocytin-filled cells through the z stacks using ImageJ
software and the cell counter plugin. Counting was performed independently by two colleagues blinded to the experimental condi-
tions, and the results were averaged.
Statistics
Data are given as mean ± standard error of the mean (SEM). N refers to the number of animals and n to the numbers of brain slices
investigated. Those numbers are indicated in the figure legends or in the text. Data were tested using analysis of variance (ANOVA)
followed by Tukey’s test (Gaussian datasets) or the Kruskal–Wallis test followed by Dunn’s test (non-Gaussian datasets). In case two
groups were compared, a t-test was applied. Differences were regarded as significant at *p < 0.05 or **p < 0.01. Tests were per-
formed with the software R (R Development Core Team, URL http://www.R-project.org).e3 Cell Reports 34, 108642, January 19, 2021
